✦ LIBER ✦

A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates: Eastern Cooperative Oncology Group study E1E96

✍ Scribed by Scott Wadler; Donna Levy; Helen L Frederickson; Carla I Falkson; Yuexian Wang; Edie Weller; Robert Burk; Gloria Ho; Anna S Kadish

Book ID: 113959144
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 133 KB
Volume: 92
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2003.12.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Daily Perillyl Alcoh

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

✍ Howard H. Bailey; Donna Levy; Linda S. Harris; Julian C. Schink; Francine Foss; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Phase II study of interleukin-12 for tre

Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group

✍ Martha Q. Lacy; Susanna Jacobus; Emily A. Blood; Neil E. Kay; S. Vincent Rajkuma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 248 KB

The Eastern Cooperative Oncology Group (ECOG) conducted a phase II trial of interleukin-12 (IL-12) for plateau phase multiple myeloma. Patients were initially treated with IL-12 250 ng/kg I.V. daily for 5 days every 3 weeks. The trial was modified due to toxicity after the first 16 patients. IL-12 w

Phase II trial of gemcitabine in patient

Phase II trial of gemcitabine in patients with advanced sarcomas (E1797) : A trial of the Eastern Cooperative Oncology Group

✍ Scott Okuno; Louise M. Ryan; John H. Edmonson; Dennis A. Priebat; Ronald H. Blum 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## BACKGROUND The current study was conducted to evaluate the antitumor activity and toxicity of gemcitabine in patients with advanced sarcoma. ## METHODS Twenty‐five patients with advanced sarcomas, who previously were untreated for metastatic disease, were treated on an Eastern Coo

Phase II trial of paclitaxel and nedapla

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study

✍ Munetaka Takekuma; Yasuyuki Hirashima; Kimihiko Ito; Hiroshi Tsubamoto; Tsutomu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Phase 2 trial of sorafenib in patients w

Phase 2 trial of sorafenib in patients with advanced urothelial cancer : A Trial of the Eastern Cooperative Oncology Group

✍ Robert Dreicer; Hailun Li; Mark Stein; Robert DiPaola; Michael Eleff; Bruce J. R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 3 views

Phase II trial of trimetrexate for patie

Phase II trial of trimetrexate for patients with advanced gastric carcinoma : An Eastern Cooperative Oncology Group Study (E1287)

✍ Ramesh K. Ramanathan; Stuart Lipsitz; Robert F. Asbury; Raman Qazi; Bernard R. G 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## BACKGROUND. A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated with trimetrexate (TMTX) who had not had prior chemotherapy. ## METHODS. Thirty-three patients with unresectable or metast